🔴 MDxHealth is trading 11.4% down in after-hours trading after suspending full-year 2026 revenue guidance

MDxHealth is trading at $0.53, down 11.40% in after-hours trading after suspending its $110–115 million 2026 revenue guidance.

• Preliminary Q3 revenue was $22.7 million, matching the prior-year quarter.
• Management attributed the shortfall to unexpected sales-force turnover after Resolve mdx was discontinued; the company plans to report full Q3 results on November 12.
• No after-hours trading-volume data was provided.